MOSAIC IMMUNOENGINEERING, INC.: 10-Q filed 2015-04-14
What MOSAIC IMMUNOENGINEERING, INC. reported in its quarterly report filed 2015-04-14 (fiscal Q3 2015): 26 published measures, 67 facts as tagged in accession 0001019687-15-001432.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-04-14
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001019687-15-001432 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MOSAIC IMMUNOENGINEERING, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 5,577,608 | USD | |
| At 2014-05-31 | 6,801,393 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 69,195 | USD | |
| At 2014-05-31 | 290,143 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 5,508,413 | USD | |
| At 2014-05-31 | 6,511,250 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 3,012,444 | USD | |
| At 2014-05-31 | 4,716,208 | USD | |
| At 2014-02-28 | 5,861,992 | USD | |
| At 2013-05-31 | 7,572,887 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 25,282 | USD | 90 |
| 2014-06-01 to 2015-02-28 | -1,002,837 | USD | 273 |
| 2013-12-01 to 2014-02-28 | -396,010 | USD | 90 |
| 2013-06-01 to 2014-02-28 | -815,648 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | -1,012,000 | USD | 273 |
| 2013-06-01 to 2014-02-28 | -1,196,234 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | 1,242 | USD | 273 |
| 2013-06-01 to 2014-02-28 | 0 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | -57,270,953 | USD | |
| At 2014-05-31 | -56,268,116 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 398,548,318 | shares | 90 |
| 2014-06-01 to 2015-02-28 | 398,548,318 | shares | 273 |
| 2013-12-01 to 2014-02-28 | 401,933,416 | shares | 90 |
| 2013-06-01 to 2014-02-28 | 402,122,360 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 401,392,948 | shares | 90 |
| 2014-06-01 to 2015-02-28 | 398,548,318 | shares | 273 |
| 2013-12-01 to 2014-02-28 | 401,933,416 | shares | 90 |
| 2013-06-01 to 2014-02-28 | 402,122,360 | shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | 2,400 | USD | 273 |
| 2013-12-01 to 2014-02-28 | -10,425 | USD | 90 |
| 2013-06-01 to 2014-02-28 | 25,288 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 2,440 | USD | |
| At 2014-05-31 | 2,775 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | 0 | USD | 273 |
| 2013-06-01 to 2014-02-28 | 62,418 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 5,568,916 | USD | |
| At 2014-05-31 | 6,699,601 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 69,195 | USD | |
| At 2014-05-31 | 290,143 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 23,400 | USD | |
| At 2014-05-31 | 224,059 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | 0 | USD | 273 |
| 2013-06-01 to 2014-02-28 | 84,129 | USD | 273 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 247,668 | USD | 90 |
| 2014-06-01 to 2015-02-28 | 977,666 | USD | 273 |
| 2013-12-01 to 2014-02-28 | 379,004 | USD | 90 |
| 2013-06-01 to 2014-02-28 | 1,191,149 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 247,668 | USD | 90 |
| 2014-06-01 to 2015-02-28 | 977,666 | USD | 273 |
| 2013-12-01 to 2014-02-28 | 379,004 | USD | 90 |
| 2013-06-01 to 2014-02-28 | 1,191,149 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 401,392,948 | shares | |
| At 2014-05-31 | 401,392,948 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 77,400,852 | USD | |
| At 2014-05-31 | 77,400,852 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 3,036 | USD | |
| At 2014-05-31 | 3,036 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 45,795 | USD | |
| At 2014-05-31 | 62,485 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | 1,577 | USD | 273 |
| 2013-06-01 to 2014-02-28 | 1,728 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 271,981 | USD | 90 |
| 2014-06-01 to 2015-02-28 | -27,005 | USD | 273 |
| 2013-12-01 to 2014-02-28 | -27,431 | USD | 90 |
| 2013-06-01 to 2014-02-28 | 360,206 | USD | 273 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2015-02-28 | 9,954 | USD | 273 |
| 2013-06-01 to 2014-02-28 | 3,900 | USD | 273 |
Inspect the source
- Entity
- MOSAIC IMMUNOENGINEERING, INC. / CIK 0000836564
- Captured
- 2026-09-19T15:08:56.564Z
- SEC response SHA-256
20b7dbddee8b1aee5cb56cb4cf5c3c14c36ef1fafb538ec0211cfb2585ddf3fd
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000836564.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))